Table 2.
Pre-ES | Post-ES | 2-way ANOVA (P) | |||||
---|---|---|---|---|---|---|---|
ACL lesion | Health control | ACL lesion | Healthy control | Interaction | Main effect time | Main effect group | |
Maximal SICI (%) | |||||||
VMO | 72.79 ± 38.78 | 47.37 ± 19.50 | 41.53 ± 23.99 | 44.93 ± 16.17 | <0.001∗∗ | — | — |
VL | 71.67 ± 24.05 | 50.46 ± 20.41 | 51.49 ± 20.78 | 45.11 ± 18.38 | 0.015∗∗ | — | — |
RF | 72.15 ± 42.87 | 54.31 ± 29.72 | 55.44 ± 16.68 | 45.13 ± 23.07 | 0.446 | 0.012∗ | 0.088 |
Maximal ICF (%) | |||||||
VMO | 205.02 ± 73.47 | 162.04 ± 38.97 | 137.89 ± 59.85 | 155.02 ± 43.80 | 0.001∗∗ | — | — |
VL | 187.61 ± 83.95 | 154.11 ± 35.65 | 135.12 ± 25.74 | 142.77 ± 25.20 | 0.048∗∗ | — | — |
RF | 181.81 ± 74.87 | 166.44 ± 64.56 | 141.41 ± 40.10 | 133.31 ± 39.01 | 0.731 | 0.001∗ | 0.426 |
M wave (mv) | |||||||
VMO | 3.28 ± 2.34 | 2.40 ± 1.85 | 3.04 ± 2.03 | 2.36 ± 1.78 | 0.237 | 0.114 | 0.225 |
VL | 1.54 ± 1.20 | 1.67 ± 1.12 | 1.37 ± 1.08 | 1.57 ± 1.09 | 0.545 | 0.010∗ | 0.642 |
RF | 0.70 ± 0.27 | 0.83 ± 0.36 | 0.72 ± 0.30 | 0.82 ± 0.37 | 0.569 | 0.935 | 0.261 |
∗Significant main effect (P < 0.05). ∗∗Significant interaction (P < 0.05) between time and group.